Post-translational modifications by ubiquitin and ubiquitin-like proteins SUMO or NEDD8 are described in a multitude of cellular processes and are essential in cellular pathways and functions that are often dysregulated in cancer. This evidence concerns the gene NEDD8 and cancer.